Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-04 Sale | 2024-12-06 6:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 102,697 | $84.93 | $8,722,501 | 1,122,026 (Direct) | View |
| 2024-11-12 Sale | 2024-11-14 6:01 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 41,583 | $88.79 | $3,692,100 | 0 (Direct) | View |
| 2024-08-29 Sale | 2024-08-30 6:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $72.7 | $5,089,236 | 1,310,119 (Direct) | View |
| 2024-08-26 Sale | 2024-08-28 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $73.54 | $7,054,085 | 1,176,240 (Direct) | View |
| 2024-08-21 Sale | 2024-08-23 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $75.05 | $9,086,738 | 1,454,844 (Direct) | View |
| 2024-08-16 Sale | 2024-08-20 6:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $75.08 | $1,405,047 | 29,700 (Direct) | View |
| 2024-06-24 Sale | 2024-06-25 6:04 pm | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 4,462 | $75.57 | $337,193 | 116,600 (Direct) | View |
| 2024-06-18 Sale | 2024-06-21 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $75.91 | $1,518,199 | 9,690 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 8:33 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 61,277 | $66.07 | $4,048,400 | 1,070,875 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-06 Exercise | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 20,478 | $0 | 56,046 (Direct) | View |
| 2025-03-06 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 5,572 | $131.19 | 56,046 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 3,116 | $131.24 | 56,046 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 61,278 | $0 | 1,175,948 (Direct) | View |
| 2025-03-06 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 19,848 | $131.19 | 1,175,948 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 10,129 | $131.24 | 1,175,948 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 20,478 | $0 | 65,944 (Direct) | View |
| 2025-03-06 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 5,572 | $131.19 | 65,944 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 3,116 | $131.24 | 65,944 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 20,478 | $0 | 34,440 (Direct) | View |
| 2025-03-06 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 6,718 | $131.19 | 34,440 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-10 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 3,757 | $131.24 | 34,440 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 34,969 | $0 | 1,173,874 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 16,978 | $128.2 | 1,173,874 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 12,239 | $0 | 35,782 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 6,261 | $128.2 | 35,782 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 8,742 | $0 | 58,506 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 3,709 | $128.2 | 58,506 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 8,742 | $0 | 48,608 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 3,709 | $128.2 | 48,608 (Direct) | View |
| 2025-02-24 Exercise | 2025-02-26 6:01 pm | N/A 2033-06-22 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 7,009 | $0 | 58,238 (Direct) | View |
| 2025-02-24 Exercise | 2025-02-26 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 7,009 | $63.79 | 58,238 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 152,059 | $0 | 1,207,155 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 5:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 15,233 | $127 | 1,207,155 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 56,471 | $0 | 50,780 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 5,691 | $127 | 50,780 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 33,744 | $0 | 58,715 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 5:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 4,729 | $127 | 58,715 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:29 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 35,638 | $0 | 50,711 (Direct) | View |
| 2025-01-31 Tax Withholding | 2025-02-04 5:29 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 4,730 | $127 | 50,711 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Narula Sanjeev Executive Vice President & CFO | 22,727 | $0 | 22,727 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 215 | $83.52 | 131,512 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 6:01 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 102,697 | $0 | 1,122,026 (Direct) | View |
| 2024-12-04 Exercise | 2024-12-06 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 102,697 | $12.73 | 1,122,026 (Direct) | View |
| 2024-11-12 Exercise | 2024-11-14 6:01 pm | N/A 2030-02-17 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 41,583 | $0 | 0 (Direct) | View |
| 2024-11-12 Exercise | 2024-11-14 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 22,869 | $23.94 | 0 (Direct) | View |
| 2024-11-13 Exercise | 2024-11-14 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael President | 18,714 | $36.89 | 0 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 246 | $73.17 | 117,108 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-30 6:01 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $0 | 1,310,119 (Direct) | View |
| 2024-08-29 Exercise | 2024-08-30 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 70,000 | $12.73 | 1,310,119 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-28 6:00 pm | N/A 2025-01-02 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $0 | 1,176,240 (Direct) | View |
| 2024-08-26 Exercise | 2024-08-28 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 95,925 | $17.57 | 1,176,240 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-23 6:00 pm | N/A 2025-01-02 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $0 | 1,454,844 (Direct) | View |
| 2024-08-21 Exercise | 2024-08-23 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 121,073 | $17.57 | 1,454,844 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A 2031-02-22 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $0 | 29,700 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 6:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 18,714 | $36.89 | 29,700 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 6:01 pm | N/A 2034-08-11 | Intra-Cellular Therapies Inc. | ITCI | Narula Sanjeev Executive Vice President & CFO | 52,297 | $0 | 52,297 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 83 | $68.49 | 11,340 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-02 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 262 | $68.49 | 116,862 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 1,567 | $0 | 11,257 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director | 1,567 | $0 | 1,567 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 6:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 1,567 | $0 | 51,229 (Direct) | View |
| 2024-06-24 Exercise | 2024-06-25 6:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $16.86 | 116,600 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 6:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 21,567 | $0 | 116,600 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-21 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $16.86 | 9,690 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-21 6:00 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $0 | 9,690 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director | 7,273 | $0 | 7,273 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 6:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 7,273 | $0 | 7,273 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 6:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 7,273 | $0 | 7,273 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 7,273 | $0 | 7,273 (Direct) | View |
| 2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 8,638 | $16.86 | 1,287,327 (Direct) | View |
| 2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 20,020 | $0 | 1,287,327 (Direct) | View |
| 2024-04-24 Exercise | 2024-04-25 5:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman and CEO | 11,382 | $17.57 | 1,287,327 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 79 | $69.2 | 9,690 (Direct) | View |
| 2024-03-31 Option Award | 2024-04-02 4:15 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 260 | $69.2 | 99,495 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A 2024-03-21 | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $0 | 99,235 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:12 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 20,000 | $18.56 | 99,235 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-11 8:33 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 20,565 | $0 | 1,070,875 (Direct) | View |